LMRLarge Molecule Research · Driven by data & AI

Molecules by design.

70% fewer molecules requiring experimental characterization.

BioAIM helps scientists identify the right biologic candidates earlier by combining predictive AI, computational biology, and experimental data to support smarter discovery decisions.

From evaluating developability and manufacturability to focusing laboratory efforts on the most promising molecules, BioAIM empowers researchers to design better biologics with greater confidence.

03 · Applied Today

Predictive models throughout the biologics discovery workflow.

BioAIM integrates predictive models throughout the biologics discovery workflow, supporting lead identification, developability assessment, candidate optimization, and preparation for successful development. By helping scientists prioritize the most promising biologic candidates earlier, BioAIM advances the strongest candidates with greater confidence.

AI supports antibody sequence optimization
Predict molecule properties earlier
Accelerates biologic candidate selection
Improves confidence in discovery decisions
Advances next-generation biologic therapies
Story · 03 Applied Today
01Predictive models support lead identification
to move between stages · Stage 3 of 5 · LMR
Smarter decisions.Better biologics.Better medicines.

Helping scientists identify the right biologic candidates earlier and with greater confidence.

LMR original poster
Original poster · click anywhere or press Esc to close
Next program: TDSB